sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 201-225 out of 1342.

<< < 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 > >>

Public Release: 21-Feb-2017
PLoS Medicine
Modern housing associated with reduced malaria risk in sub-Saharan Africa
Modern houses -- with metal roofs and finished walls -- are associated with a more than 9 percent reduction in the odds of malaria in children in sub-Saharan Africa when compared to more traditional thatched houses, according to a study published in PLOS Medicine by Lucy Tusting of the University of Oxford, UK, and colleagues at the London School of Hygiene & Tropical Medicine, UK, Durham University, UK, and the University of Southampton, UK.

Contact: Lucy S. Tusting
lucy.tusting@well.ox.ac.uk
PLOS

Public Release: 20-Feb-2017
Journal of Global Oncology
New approach to cervical cancer care in Botswana cuts treatment lag time in half
Cervical cancer is the leading cause of cancer deaths for women low- and middle-income countries, including Botswana, where 75 percent of cervical cancer patients suffer from advanced forms of the disease. These patients can face wait times as long as five months after diagnosis before receiving lifesaving treatment. A new, multidisciplinary model of cervical cancer care developed by a University of Pennsylvania team based in Botswana cut the delay between diagnosis and treatment by more than 50 percent.

Contact: Johanna Harvey
johanna.harvey@uphs.upenn.edu
215-349-8062
University of Pennsylvania School of Medicine

Public Release: 20-Feb-2017
University of Louisville researcher to investigate how gut microbiota protect against malaria
Schmidt intends to pursue further research to determine which microbes are responsible for protecting against malaria illness and to learn more about the mechanism behind that protection
NIH/National Institute of Allergy and Infectious Diseases

Contact: Betty Coffman
betty.coffman@louisville.edu
502-852-4573
University of Louisville

Public Release: 20-Feb-2017
Proceedings of the National Academy of Sciences
Experimental vaccine protects against multiple malaria strains
An experimental malaria vaccine protected healthy subjects from infection with a malaria strain different from that contained in the vaccine, according to a new study.

Contact: David Kohn
dkohn@som.umaryland.edu
410-706-7590
University of Maryland School of Medicine

Public Release: 17-Feb-2017
New grant boosts UC San Diego-led malaria research program
An international research team, led by principal investigator Elizabeth A. Winzeler, Ph.D., professor in the pediatric division of host-microbe systems and therapeutics at University of California San Diego School of Medicine, and colleagues have received a three-year, $4.7 million supplemental grant from the Bill & Melinda Gates Foundation to advance their development of improved therapies for malaria eradication and elimination.
Bill & Melinda Gates Foundation

Contact: Scott LaFee
slafee@ucsd.edu
858-249-0456
University of California - San Diego

Public Release: 17-Feb-2017
Stem Cell Reports
UTMB scientists uncover how Zika virus causes microcephaly
A multidisciplinary team from The University of Texas Medical Branch at Galveston has uncovered the mechanisms that the Zika virus uses to alter brain development. These findings are detailed in Stem Cell Reports.

Contact: Donna Ramirez
donna.ramirez@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston

Public Release: 17-Feb-2017
2017 AAAS Annual Meeting
Yeast found in babies' guts increases risk of asthma
University of British Columbia microbiologists have found a yeast in the gut of new babies in Ecuador that appears to be a strong predictor that they will develop asthma in childhood. The new research furthers our understanding of the role microscopic organisms play in our overall health.

Contact: Heather Amos
heather.amos@ubc.ca
604-828-3867
University of British Columbia

Public Release: 16-Feb-2017
RNA
Method developed by biomedical scientists could help in treatment of several diseases
Nonsense-mediated RNA decay (NMD) is a processing pathway in cells that, like a broom, cleans up erroneous RNA. Biomedical scientists in the School of Medicine at the University of California, Riverside report that they have come up with a method in the lab that detects NMD efficiency inside the cell.
National Institutes of Health

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 16-Feb-2017
American Journal of Human Biology
People far from urban lights, bright screens still skimp on sleep
Screen time before bed can mess with your sleep. But people without TV and laptops skimp on sleep too, researchers say. A Duke University study of people living without electricity or artificial light in a remote farming village in Madagascar finds they get shorter, poorer sleep than people in the US or Europe. But they seem to make up for lost shuteye with a more regular sleep routine, the researchers report.
Duke University Bass Connections program, Duke Global Health Institute

Contact: Robin Ann Smith
ras10@duke.edu
919-681-8057
Duke University

Public Release: 16-Feb-2017
CROI 2017
Turning the corner on the HIV epidemic in Zimbabwe, Malawi, and Zambia
Newly released findings from national HIV surveys in Zimbabwe, Malawi, and Zambia reveal extraordinary progress in confronting the HIV epidemic. These three countries in Southern Africa have been heavily affected by HIV, and now there are encouraging signs that the epidemics are going in the right direction.
US President's Emergency Plan for AIDS Relief, US Centers for Disease Control and Prevention

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health

Public Release: 16-Feb-2017
Alliance for Cancer Gene Therapy announces 2 new cancer grant recipients for 2017
Alliance for Cancer Gene Therapy Awards Young Investigator Grants to Marco Gallo, Ph.D., of the University of Calgary, and Greg Delgoffe, Ph.D., of the University of Pittsburgh. ACGT is supporting Dr. Gallo's research into the cellular anomalies in glioblastoma brain cancer and Dr. Delgoffe's research into metabolically reprogramming tumor-specific T cells for treating solid tumors including melanoma.
Alliance for Cancer Gene Therapy

Contact: Jenifer Howard
jhoward@jhowardpr.com
203-273-4246
Alliance for Cancer Gene Therapy

Public Release: 16-Feb-2017
ESMO supports the 2017 WHO cancer resolution
ESMO, the leading European professional organization for medical oncology, presented an official statement supporting the 2017 WHO Cancer Resolution that was discussed at the 140th session of the WHO Executive Board meeting in Geneva, Jan. 23-31.

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

Public Release: 16-Feb-2017
Journal of Insect Science
For mosquito repellents, stick with the spray
In a crowded marketplace of products advertised to repel mosquitos, consumers are wise to trust spray-on repellents containing DEET or PMD, say researchers at New Mexico State University. In a comparison study of several mosquito-repellent products, 'wearable' devices such as bracelets or sonic repellers were found to be largely ineffective in repelling Aedes aegypti mosquitoes.

Contact: Joe Rominiecki
jrominiecki@entsoc.org
301-731-4535 x3009
Entomological Society of America

Public Release: 15-Feb-2017
Lancet Infectious Diseases
Investigational malaria vaccine shows considerable protection in adults in malaria season
An investigational malaria vaccine given intravenously was well-tolerated and protected a significant proportion of healthy adults against infection with Plasmodium falciparum malaria -- the deadliest form of the disease -- for the duration of the malaria season, according to new findings published in the Feb. 15th issue of the journal Lancet Infectious Diseases. The study participants live in Mali, Africa, where they are naturally exposed to the parasite.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 15-Feb-2017
Nature
Study: Experimental malaria vaccine plus chloroquine protects against controlled infection
An experimental malaria vaccine strategy known as PfSPZ-CVac, together with antimalarial medication, protected all nine clinical trial volunteers given three high-dose vaccinations, according to study results published today in Nature.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Elizabeth Deatrick
elizabeth.deatrick@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 15-Feb-2017
PLOS Neglected Tropical Diseases
New protein could be key in fighting debilitating parasitic disease
A naturally occurring protein has been discovered that shows promise as a biocontrol weapon against schistosomiasis, one of the world's most prevalent parasitic diseases, Oregon State University researchers reported today in a new study.

Contact: Euan Allan
steve.lundeberg@oregonstate.edu
541-737-2993
Oregon State University

Public Release: 15-Feb-2017
Molecular Psychiatry
Bipolar disorder candidate gene, validated in mouse experiment
Researchers at Ulsan National Institute of Science and Technology (UNIST) in South Korea has made a significant breakthrough in the search for the potential root causes of bipolar disorder.
Future Creation Science Department, Korea Research Foundation

Contact: JooHyeon Heo
joohyeonheo@unist.ac.kr
82-522-171-223
Ulsan National Institute of Science and Technology(UNIST)

Public Release: 15-Feb-2017
Bioinformatics
Ebolaviruses need very few mutations to cause disease in new host species
Ebola is one of the world's most virulent diseases, though rodent species such as guinea pigs, rats and mice are not normally susceptible to it. However, through repeated infection of a host animal, Ebola virus strains can be generated that replicate and cause disease within new host rodent species.

Contact: Sandy Fleming
S.Fleming@kent.ac.uk
44-012-278-23581
University of Kent

Public Release: 15-Feb-2017
Nature
New malaria vaccine effective in clinical trial
University of Tuebingen researchers in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria® PfSPZ-CVac has been up to 100 percent effective when assessed at 10 weeks after last dose of vaccine. For the trial, Professor Peter Kremsner and Dr. Benjamin Mordmueller of the Institute of Tropical Medicine and the German Center for Infection Research used malaria parasites provided by Sanaria.

Contact: Peter Kremsner
peter.kremsner@uni-tuebingen.de
49-707-129-87179
German Center for Infection Research

Public Release: 15-Feb-2017
Science Translational Medicine
International study suggests Nodding syndrome caused by response to parasitic protein
Researchers at the National Institutes of Health have uncovered new clues to the link between Nodding syndrome, a devastating form of pediatric epilepsy found in specific areas of east Africa, and a parasitic worm that can cause river blindness. The study, published in Science Translational Medicine, suggests that the mysterious neurological disease may be caused by an autoimmune response to the parasitic proteins.
National Institutes of Health

Contact: Barbara McMakin
nindspressteam@ninds.nih.gov
NIH/National Institute of Neurological Disorders and Stroke

Public Release: 15-Feb-2017
European Journal of Preventive Cardiology
Statin side effects are strongest predictor of failure to meet cholesterol targets
Statin side effects are the strongest predictor of failure to meet low-density lipoprotein (LDL) cholesterol targets, according to research published today in the European Journal of Preventive Cardiology. Other predictors were statin non-adherence and use of weaker statins.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 14-Feb-2017
Retrovirology
Only a limited HIV subset moves from mother to child, study shows
In the transmission of HIV-1 from mother to child only a subset of a mother's viruses infects their infants either in utero or via breastfeeding, and the viruses that are transmitted depend on whether transmission occurs during pregnancy or through breastfeeding
National Institutes of Health, NIH/National Institute of Child Health and Human Development, International Maternal Pediatric Adolescent AIDS Trials Group

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-267-7120
University of California - Los Angeles Health Sciences

Public Release: 14-Feb-2017
Conference on Retroviruses and Opportunistic Infections (CROI)
Study confirms key therapeutic advance for children living with HIV and tuberculosis
Landmark study proves that 'super-boosting' approach counters negative interaction between key HIV and TB drugs The non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi) has released results of a study in South Africa that will make it easier for healthcare workers to treat children living with HIV who are co-infected with tuberculosis (TB).

Contact: Ilan Moss
imoss@dndi.org
646-266-5216
Drugs for Neglected Diseases Initiative

Public Release: 14-Feb-2017
IDRI & NanoPass sign agreement to develop an intradermal rvRNA-based Zika virus vaccine
IDRI (Infectious Disease Research Institute) and NanoPass Technologies have signed a collaboration agreement to develop and test a new Zika vaccine based on a replicating viral RNA (rvRNA) construct administered intradermally using NanoPass's proprietary MicronJet600® microneedle device.

Contact: Lee Schoentrup
lee.schoentrup@idri.org
206-858-6064
Infectious Disease Research Institute

Public Release: 13-Feb-2017
Proceedings of the National Academy of Sciences
Disease 'superspreaders' were driving cause of 2014 Ebola epidemic
A new study about the overwhelming importance of 'superspreaders' in some infectious disease epidemics has shown that in the catastrophic 2014-15 Ebola epidemic in West Africa, about 3 percent of the people infected were ultimately responsible for infecting 61 percent of all cases. Researchers are now learning more about who these people are.
Bill and Melinda Gates Foundation, National Institutes of Health, UK Medical Research Council

Contact: Benjamin Dalziel
benjamin.dalziel@oregonstate.edu
541-737-1979
Oregon State University

Showing releases 201-225 out of 1342.

<< < 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 > >>